Development and characterization of dengue virus (DENV)-based RNA vector
Despite the prevalent use of mRNA vaccines, from protein replacement therapy to infectious diseases and cancer, their accessibility remains limited, particularly to low- and middle-income countries. Here, the development and in vitro characterization of a DENV-based RNA vector (DV-RNA) is described, which can overcome...